tcrLM:一种用于预测T细胞受体与表位结合特异性的轻量级蛋白质语言模型
tcrLM: a lightweight protein language model for predicting T cell receptor and epitope binding specificity
AI总结:
本研究针对TCR多样性导致抗原-TCR结合预测困难的问题,提出轻量级掩码语言模型tcrLM,通过掩码训练、虚拟对抗训练及基于超1亿条序列的预训练,在多测试集上性能优于现有方法和主流蛋白语言模型,还可指示免疫治疗反应与临床结果。
摘要:
抗癌免疫反应依赖于T细胞受体(TCRs)与抗原之间的结合,这种结合会引发适应性免疫以清除肿瘤细胞。免疫系统对各种新型肿瘤抗原产生反应的能力源于TCR库的巨大多样性。然而,TCR多样性对准确预测抗原-TCR结合构成了重大挑战。在本研究中,我们引入了一种名为tcrLM的轻量级掩码语言模型来应对这一挑战。我们的方法包括随机掩码TCR序列的片段,并训练tcrLM推断被掩码的片段,从而能够从TCR序列中提取具有表达性的特征。为了进一步增强鲁棒性,我们将虚拟对抗训练整合到tcrLM中。我们构建了最大的TCR CDR3序列集,包含超过1亿条不同的序列,并在这些序列上预训练tcrLM。预训练的编码器随后被应用于预测TCR-抗原结合特异性。我们在三个测试数据集上评估模型性能:独立测试集、外部测试集和COVID-19测试集。结果表明,tcrLM不仅优于现有的TCR-抗原结合预测方法,还优于其他主流蛋白质语言模型。更有趣的是,tcrLM能有效捕捉TCR序列中氨基酸的生化特性和位置偏好。此外,预测的TCR-新抗原结合分数可指示黑色素瘤队列中的免疫治疗反应和临床结果。这些发现证明了tcrLM在预测TCR-抗原结合特异性方面的潜力,对推进免疫治疗和个性化医疗具有重要意义。
英文摘要:
The anti-cancer immune response relies on the bindings between T-cell receptors (TCRs) and antigens, which elicits adaptive immunity to eliminate tumor cells. This ability of the immune system to respond to novel various neoantigens arises from the immense diversity of TCR repository. However, TCR diversity poses a significant challenge on accurately predicting antigen-TCR bindings. In this study, we introduce a lightweight masked language model, termed tcrLM, to address this challenge. Our approach involves randomly masking segments of TCR sequences and training tcrLM to infer the masked segments, thereby enabling the extraction of expressive features from TCR sequences. To further enhance robustness, we incorporate virtual adversarial training into tcrLM. We construct the largest TCR CDR3 sequence set with more than 100 million distinct sequences, and pretrain tcrLM on these sequences. The pre-trained encoder is subsequently applied to predict TCR-antigen binding specificity. We evaluate model performance on three test datasets: independent, external, and COVID-19 test set. The results demonstrate that tcrLM not only surpasses existing TCR-antigen binding prediction methods, but also outperforms other mainstream protein language models. More interestingly, tcrLM effectively captures the biochemical properties and positional preference of amino acids within TCR sequences. Additionally, the predicted TCR-neoantigen binding scores indicates the immunotherapy responses and clinical outcomes in a melanoma cohort. These findings demonstrate the potential of tcrLM in predicting TCR-antigen binding specificity, with significant implications for advancing immunotherapy and personalized medicine.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。